LivsMed Inc. (Ticker: 491000 KS) is a South Korean medical device manufacturer specializing in the development of advanced tools for minimally invasive surgery. The company plans to list on the KOSDAQ exchange on December 24, 2025. LivsMed intends to offer 2.47 million new shares within a target price range of KRW 44,000 to KRW 55,000 per share. At the lower end of this range, the offering aims to raise approximately KRW 108.7 billion (roughly $73.9 million USD).

LivsMed focuses on handheld multi-joint laparoscopic surgical instruments, marketed primarily under the brand ArtiSential. Unlike traditional straight instruments, these devices are designed to replicate the articulation of the human wrist, providing surgeons with 90-degree dexterity in all directions within narrow surgical cavities. The company is also commercializing the ArtiSeal vascular sealer and developing the LivsCam 3D4K camera system. Samsung Securities and Mirae Asset Securities are acting as the lead underwriters for the deal.